20 Years of Th17 Cells: Discovery and Clinical Impact  

20 Years of Th17 Cells: Discovery and Clinical Impact  

Saturday, April 18, 2026
8:00 AM – 11:30 AM
Room 205 

MAJOR SYMPOSIUM F 

20 years of Th17 cells: discovery and clinical impact  

Chairs: 

Sarah L. Gaffen, Univ. of Pittsburgh, USA 

Vijay K. Kuchroo, Gene Lay Inst. of Immunol. and Inflammation, USA 

Speakers: 

Daniel Cua, Johnson & Johnson, IL-23 regulation of Th17 immune pathway in autoimmune inflammation 

Sarah L. Gaffen, Univ. of Pittsburgh, USA, At the crossroads of IL-17 signaling: IL-17 signal transduction in autoimmunity and fungal infections 

Jun R. Huh, Harvard Med. Sch., USA, TBD 

Dan R. Littman, HHMI, NYU Sch. of Med., USA, The immune cellular network defined by ROR𝛾t 

Mandy J. McGeachy, Cornell Univ., USA, Th17 influencers